Q&A: Investing in Life Science
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing. Read more
15 Apr 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
Scotland’s Life Sciences Sector Poised for Growth
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland. Read more
14 Mar 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
UK biotech company responds to approval changes and R&D tax relief
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget. Read more
23 Mar 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Why invest in pharma in times of a recession?
Léone Atayi, CEO of Hybrigenics and Stemcis, discusses the importance of investing in the pharmaceutical industry amid a recession. Read more
21 Feb 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Smart Financing and CROs: investing in digitalisation for drug development
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology. Read more
5 Oct 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Q&A with Lonza: Support for biotech startups
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation. Read more
29 Jun 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Asceneuron secures $100m funding to advance therapeutics in neurodegenerative diseases
Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, has announced a 100 million USD oversubscribed Series C financing round. Read more
18 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Rhenopharma Group acquires Swiss contract manufacturer Konapharma AG
Within the new group of companies, Konapharma now complements the services of packaging company Allpack and Rhenochem, a family-owned company with decades of extensive experience and expertise in the global pharmaceutical industry. Read more
1 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Cycle Pharma Offers $466 Million to Acquire Vanda Pharmaceuticals
Cycle Pharmaceuticals a rapidly growing pharmaceutical company focused on treatments for the underserved rare disease patient community, have confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc. Read more
10 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
What’s trending in point-of-care diagnostics?
Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways. Read more
17 Jul 2024
The Practical Impact of Generative AI in Life Science Manufacturing
Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability. Read more
16 Jul 2024
A Short Guide to Stability Studies
Paul Barr, Principal Scientist at Broughton, outlines the key factors when it comes to stability testing for drug delivery devices. Read more
28 Jun 2024
How Ready Are You? Annex 1 and the Impact of Primary Packaging
Niamh Bissett, Director, Operations, PMO, West Pharmaceutical Services discusses Annex 1 and the Impact of Primary Packaging in our latest EPM Online insight. Read more
18 Jun 2024
Q&A: Purolite's Felix Solamo
We caught up with Purolite's Felix Solamo to look back on Bio International 2024. Read more
18 Jun 2024
Patent Lifecycle Management is Key for Cell and Gene Therapy Innovators
Justin Wilson, partner and pharmaceuticals & gene therapy sector specialist at European intellectual property law firm Withers & Rogers explores how patent lifecycle management is key for cell and gene therapy innovators. Read more
17 Jun 2024
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more